Cytotoxicity

Cytotoxicity describes the capacity of a substance to harm or kill cells. It is measured most often in laboratory cultures — isolated hepatocytes, neuronal cell lines, or kidney cells exposed to increasing concentrations of a compound — and expressed as an IC₅₀ or LC₅₀: the concentration at which half the cells are impaired or dead.

The important context is what these figures mean and what they do not. A cultured cell has no liver to metabolise the compound, no blood to dilute it, no excretion to clear it. In vitro cytotoxicity is a screening signal, not a verdict on real-world safety — but it is an early warning worth taking seriously when it appears.

How it works · its role

Substances cause cell damage through several distinct mechanisms. Many generate reactive oxygen species that overwhelm the cell's antioxidant defences, damaging lipid membranes, proteins, and DNA. Others disrupt mitochondrial function, cutting off the energy supply and triggering either controlled cell death (apoptosis) or catastrophic rupture (necrosis). Some interfere with ion channels, flooding the cell with calcium that activates destructive enzymes.

Importantly, a compound does not have to be directly toxic — its metabolites may be the problem. Cells with high metabolic activity, such as hepatocytes and neurons, are especially exposed to reactive breakdown products formed during drug metabolism. This is why cytotoxicity is often assessed separately in metabolically active cells and in simpler cell lines.

Relevance to substances & effects

Cytotoxicity comes up most often in two contexts on these pages: hepatotoxicity and neurotoxicity. The liver is the primary site of drug metabolism, which makes hepatocytes both the most studied cell type and the most frequently harmed. Alcohol is a well-established example: its primary metabolite acetaldehyde is directly cytotoxic to liver cells at the cellular level.

Several substituted amphetamines — particularly MDMA — have been associated with serotonergic neurotoxicity at high or repeated doses in animal studies. Whether those findings translate to human exposure at typical doses remains debated; the concentration gap between animal models and human tissue is substantial. Similar caveats apply to many novel psychoactive substances, where in vitro cytotoxicity profiles exist long before controlled human data do.

A useful frame for reading cytotoxicity data: a low IC₅₀ in the nanomolar range in neuronal cultures is more concerning than one in the millimolar range, because the former is closer to concentrations that might plausibly occur in tissue. When a substance page flags cytotoxicity concerns, that figure and cell type are the details that matter.